To The Moon

Anthropic’s Claude models have created a massive sell-off is Sofware-as-a-Service businesses, as investors run away from disruption. My colleague Hazel prepared the above overview of the worst-performing stocks YTD. As you can see, it is dominated by SaaS names. $Intuit(INTU)$ is down 33% $Gartner(IT)$ is down 33% $ServiceNow(NOW)$ is down 28% $Workday(WDAY)$ is down 26% This fear is rational, as historically, SaaS monetised its services through seat-based pricing. This was a very straightforward way to monetise software. The more features were added, the more usefull software became. Each incremental feature served as a

YTD Worst Performing S&P 500 $S&P 500(.SPX)$ Stocks: 🔴 -37% $Gartner(IT)$ 🔴 -36% $Intuit(INTU)$ 🔴 -30% $ServiceNow(NOW)$ 🔴 -30% $AppLovin Corporation(APP)$ 🔴 -29% $FactSet Research(FDS)$ 🔴 -29% $Humana(HUM)$ 🔴 -29% $PayPal(PYPL)$ 🔴 -29% $Workday(WDAY)$ 🔴 -28% $Coinbase Global, Inc.(COIN)$ 🔴 -28% $Salesforce.com(CRM)$ 🔴 -26%

Which ticker is the most likely to 3x in 3 years? A potential 3x return over the next three years is not about picking the biggest or safest company—it’s about identifying the rare intersection of structural tailwinds, operating leverage, and market mispricing. The tickers below span energy storage, space, fintech, crypto infrastructure, AI-driven data platforms, and healthcare—each with a credible bull case, but very different risk profiles. The goal is not to predict certainty, but to assess which business has the clearest path to tripling its valuation if execution, industry momentum, and capital markets align. - $Eos Energy Enterprises Inc.(EOSE)$ at $13 - $Ondas Holdings Inc.(ONDS)$ at $10 -

Today, millions of investors and ordinary people know of $Novo-Nordisk A/S(NVO)$ because of its world-famous, highly effective, and revolutionary drug called Ozempic. When Ozempic was released in 2017, no one could have imagined it would become a global media sensation. Celebrities such as Kim Kardashian, Oprah, and Adele appeared noticeably slimmer in public after rumors that they had used Ozempic. This made Ozempic the topic of general and entertainment news, and an incredibly rare feat for a medicinal drug. Understandably, as the word spread of Ozempic’s incredible weight-loss effects to all corners of the world, the demand for the drug exploded. This free media exposure allowed Novo Nordisk to achieve incredible financial results. In just 6 yea

$Hims & Hers Health Inc.(HIMS)$ has some balls. Leadership taking big swings and striking out every once in awhile is not necessarily a bad thing. Big thinkers and innovators play big. Often in the gray areas...seeing that now with the $nvo lawsuit. Move fast and break things. All the hyper growth players looked reckless early on...and made stupid mistakes when trying to really lift off. $Robinhood(HOOD)$ halted trading during the $GameStop(GME)$ saga. $Uber(UBER)$ launched in cities without approval and got banned. States called $DraftKings Inc.(DKNG)$ "illegal gambling" in

It won't go down. Current admin won't let it. Every meaningful dip "tacos" within two weeks. Volatility sure, but meaningful downside? It's going to take something outside of the President's control to really roll this thing over in the first half of this year. Sure there will be many 1%-3% mini drops in $SPDR S&P 500 ETF Trust(SPY)$ next few months...but another -15% correction before midterms is less than likely. Market performance is the current admin's metric of choice...they call out the "historic stock market" seemingly daily. Will do almost anything to maintain current trajectory. Individual high-beta names will continue to get caught in little rolling bubbles, and that volatility will create opportunity for great entries in many growth-

AI names are crashing 10-20% 🔴 Yet, AI investments are accelerating - $Microsoft(MSFT)$ $100B - $Meta Platforms, Inc.(META)$ $115-135B - $Alphabet(GOOGL)$ $175-185B FOLLOW THE MONEY 💸 Here are another 10 companies that will dominate the AI age: 11/ $Meta Platforms, Inc.(META)$ $META controls the attention of the world. - 3.6B Daily Users - 15% ARPU Growth - 22% Revenue Growth - 41% EBIT Margin A few months ago, they announced new smart glasses that could bring a new form factor to the masses. And AI will turbocharge everything! Before AI, social networks relied on manual sharing and simple algorithms to surface posts an

I don't think there has ever been a bigger RED flag than $Hims & Hers Health Inc.(HIMS)$ CEO Dudum retweeting a known charlatan stock pumper course seller. This action alone should warrant his termination, but he did it a day before selling shares. Yet, HIMS investors completely ignored this obvious red flag because they were watching through rose-colored glasses. However, this was not the only red flag the company did: - Giving out an aggressive 2030 guidance was a red flag. Hims is not a mature company to know its sales 5 years in advance. Any CEO of a fast-growing company who can tell their sales 5 years from now, is either 1 lying 2 delusional 3 or trying to pump the stock. - Expanding internationally, when the US TAM is 100x, the global

New position in $SoFi Technologies Inc.(SOFI)$ . Larger allocation than usual...here's why. $S&P 500(.SPX)$ inclusion candidate. Rebalancing happens quarterly with next one being March 20th, '26. Near term catalyst. Inclusion could pop the stock 5%-10%. Anticipation alone can be a strong tailwind. Just launched crypto trading, but unlike $Robinhood(HOOD)$ $Coinbase Global, Inc.(COIN)$ $SoFi Technologies Inc.(SOFI)$ monetizes relationships...not trading volume + market activity. Revenue is tied to member LTV. Lower rates are mega bullish for SOFI too...student loan refi's, mo

The past week has been painful for the entire AI trade, but $IREN Ltd(IREN)$ has suffered more than most, falling 31% before even reporting Q4 2025 earnings. Shareholders hoping that earnings would bring back optimism in the stock were greatly disappointed, as Iren fell as much as 20% in the after-hours. This means that Iren was down close to 50% in just a few days! I believe there are 3 key reasons why the stock reacted so negatively to the earnings: No Hyperscaler Deals Revenue Miss Earnings Miss In my opinion, the market wildly overreacted to these developments. Furthermore, investors are completely ignoring the positives that Iren announced: Secured $3.6B GPU Financing New Massive Data Center Strong ARR Guidance Let’s dig deeper. 1. No Hypersc